Hutch News

Hutch News

Stories tagged 'Tumor specific translational research'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 19, 2017

Dr. Ruth Etzioni, a Fred Hutch biostatistician, has received a five-year National Institutes of Health grant to advance the science of cancer surveillance by developing, validating and deploying a scalable, automated approach for identifying cancer recurrence.

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


Closing the breast cancer divide in sub-Saharan Africa

Clinical trial in Uganda will test alternative diagnostic tool and oral chemotherapy, study genetic differences

Aug. 15, 2017 | By Mary Engel / Fred Hutch News Service

Researchers from Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute are launching a clinical study in the Ugandan capital Kampala that could change the way breast cancer in sub-Saharan Africa is diagnosed and treated.

View story >


6 things to know about glioblastoma

Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research

July 21, 2017 | By Mary Engel / Fred Hutch News Service

Our experts at Fred Hutchinson Cancer Research Center offer the long view on glioblastoma diagnosis, treatment and research in light of Sen. John McCain's recent diagnosis.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 29, 2017

Dr. Amanda Paulovich of Fred Hutch has been selected to lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer.

View story >


Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.